Abstract
The reverse genetics system commonly used for the production of hepatitis C virus (HCV), which is a major causative agent of liver diseases, involves introduction of the viral genomic RNA synthesized in vitro into human hepatoma cells by electroporation. As an alternative methodology, we describe a cell culture system based on transfection with an expression plasmid containing a full-length HCV cDNA clone flanked by RNA polymerase I promoter and terminator sequences to generate infectious virus particles from transfected cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
D’Souza S, Lau KC, Coffin CS et al (2020) Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 26:5759–5783
McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4–13
Wakita T (2016) Cell culture system for propagation of HCV. In: Miyamura T, Lemon SM, Walker CM, Wakita T (eds) Hepatitis C Virus I, cellular and molecular virology. Springer, Singapore, pp 67–80
Suzuki T (2017) Hepatitis C virus replication. In: Tagaya M, Simmen T (eds) Advances in experimental medicine and biology. Springer, Singapore, pp 199–209
Neumann G, Watanabe T, Ito H et al (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96:9345–9350
Fodor E, Devenish L, Engelhardt OG et al (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73:9679–9682
Neumann G, Watanabe T, Kawaoka Y (2000) Plasmid-driven formation of influenza virus-like particles. J Virol 74:547–551
Neumann G, Kawaoka Y (2001) Reverse genetics of influenza virus. Virology 287:243–250
Seibert B, Angel M, Caceres CJ et al (2021) Development of a swine RNA polymerase I driven influenza reverse genetics system for the rescue of type A and B influenza viruses. J Virol Methods 288:114011
Flick R, Pettersson RF (2001) Reverse genetics system for Uukuniemi virus (Bunyaviridae): RNA polymerase I-catalyzed expression of chimeric viral RNAs. J Virol 75:1643–1655
Flick R, Flick K, Feldmann H et al (2003) Reverse genetics for crimean-congo hemorrhagic fever virus. J Virol 77:5997–6006
Groseth A, Feldmann H, Theriault S et al (2005) RNA polymerase I-driven minigenome system for Ebola viruses. J Virol 79:4425–4433
Billecocq A, Gauliard N, Le May N et al (2008) RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent rift valley fever viruses. Virology 378:377–384
Pan M, Gao S, Zhou Z et al (2018) A reverse genetics system for enterovirus D68 using human RNA polymerase I. Virus Genes 54:484–492
Utt A, Rausalu K, Jakobson M et al (2019) Design and use of chikungunya virus replication templates utilizing mammalian and mosquito RNA polymerase I-mediated transcription. J Virol 93:e00794–e00719
Ikegami T (2021) Development of a simian RNA polymerase I promoter-driven reverse genetics for the rescue of recombinant rift valley fever virus from vero cells. J Virol 95:e02004–e02020
Masaki T, Suzuki R, Saeed M et al (2010) Production of infectious hepatitis C virus by using RNA polymerase I-mediated transcription. J Virol 84:5824–5835
Suzuki R, Saito K, Kato T et al (2012) Trans-complemented hepatitis C virus particles as a versatile tool for study of virus assembly and infection. Virology 432:29–38
Wakita T, Pietschmann T, Kato T, Date T et al (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791–796
Zhong J, Gastaminza P, Cheng G et al (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci U S A 102:9294–9299
Acknowledgments
We thank Dr. Mami Matsuda for her constructive suggestions. This work was supported by the Japan Agency for Medical Research and Development (AMED), under Grant Numbers JP21fk0210053, JP22fk0210086, JP22fk0210090, JP22fk0210066, JP22fk0210110, and JP22fk0210109, and by MEXT KAKENHI Grant Number JP20K08852.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Suzuki, R., Suzuki, T. (2024). Reverse Genetics of Hepatitis C Virus Using an RNA Polymerase I-Mediated Transcription. In: Pérez, D.R. (eds) Reverse Genetics of RNA Viruses. Methods in Molecular Biology, vol 2733. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3533-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3533-9_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3532-2
Online ISBN: 978-1-0716-3533-9
eBook Packages: Springer Protocols